In Phase A, members will acquire unique doses and schedules of oral ABBV-744 tablet to recognize Protected dosing program. More members is going to be enrolled within the determined monotherapy dosign regimen. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 might be presented as &